Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials

por Araki, Eiichi, Terauchi, Yasuo, Watada, Hirotaka, Deenadayalan, Srikanth, Christiansen, Erik, Horio, Hiroshi, Kadowaki, Takashi
Publicado 2021

Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trials

por Yabe, Daisuke, Deenadayalan, Srikanth, Horio, Hiroshi, Kaneto, Hideaki, Jensen, Thomas Bo, Terauchi, Yasuo, Yamada, Yuichiro, Inagaki, Nobuya
Publicado 2022

SAT-139 Clinical Impact of Oral Semaglutide Compared with Sitagliptin in T2D on Metformin ± Sulfonylurea: The Pioneer 3 Trial

por Rosenstock, Julio, Allison, Dale, Birkenfeld, Andreas, Blicher, Thalia, Deenadayalan, Srikanth, Jacobsen, Jacob, Serusclat, Pierre, Violante, Rafael, Watada, Hirotaka, Davies, Melanie
Publicado 2019